The collaboration was made possible by an almost $10 million grant from the National Institute of Mental Health, according to a Nov. 22 news release from CHOP.
The highly sensitive, wearable magnetoencephalography technology, developed by FieldLine, allows patients to move freely while the device records their brain physiology. The technology alleviates the need for patients to lie still, which can be difficult for children with profound autism, and other neurodevelopmental and intellectual disabilities, the release said.
“There is not only a societal imperative, but there is a scientific imperative to work with these children,” Timothy Roberts, PhD, vice chair of research in CHOP’s department of radiology, said in the release. “How can the scientific community generalize its findings across a spectrum of patients, if we don’t include everyone in that spectrum?”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
